Peripheral Arterial Disease
Volume II

Underestimated, Underdiagnosed and Undertreated
A Significant Opportunity for Interventional Therapies

Analyzes the peripheral interventional market in the aortoiliac, femoropopliteal and tibial vessels. Provides in-depth discussion of surgical bypass and grafts, angioplasty, stents, stent-grafts and other FDA-approved endovascular therapies. These include atherectomy, PolarCath cryoplasty, the CLiRpath excimer laser, the SilverHawk System, the cutting balloon and new devices to cross total occlusions.

Estimates current market potential for bypass surgery and endovascular therapies by disease severity and projects growth through 2020. Provides information and financial data for over 30 company participants.

Price: $4,250
 
To purchase call us at 404 816-0746 or contact witherspoon@thesagegroup.us

Table of Contents

Index of Tables and Figures

References-First and Last Pages

Sample Pages [Available on Request]